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Available online 23 July 2012Abstract Recent studies have described the occurrence of chromosomal abnormalities and mitochondrial dysfunction in human
stem/stromal cells (SCs), particularly after extensive passaging in vitro and/or expansion under low oxygen tensions. To deepen this
knowledge we investigated the influence of hypoxia (2% O2) and prolonged passaging (NP10) of human bone marrow stromal cells
(BMSCs) and adipose-derived stromal cells (ASCs) on the expression of genes involved in DNA repair and cell-cycle regulation pathways,
as well as on the occurrence of microsatellite instability and changes in telomere length. Our results show that hypoxic conditions
induce an immediate and concerted down-regulation of genes involved in DNA repair and damage response pathways (MLH1, RAD51,
BRCA1, and Ku80), concomitantly with the occurrence of microsatellite instability while maintaining telomere length. We further
searched for mutations occurring in the mitochondrial genome, and monitored changes in intracellular ATP content, membrane
potential and mitochondrial DNA content. Hypoxia led to a simultaneous decrease in ATP content and in the number of mitochondrial
genomes,whereas the opposite effectwas observed after prolonged passaging. Moreover,we show that neither hypoxia nor prolonged
passaging significantly affected the integrity of the mitochondrial genome. Ultimately, we present evidence on how hypoxia
selectively impacts the cellular response of BMSCs and ASCs, thus pointing for the need to optimize oxygen tension according to the
cell source.
© 2012 Elsevier B.V. All rights reserved.Introduction
Stem/stromal cells (SCs) consist of a population of non-
hematopoietic multipotent progenitors, able to differentiate⁎ Corresponding author. Fax: +351 218419062.
E-mail address: joaquim.cabral@ist.utl.pt (J.M.S. Cabral).
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http://dx.doi.org/10.1016/j.scr.2012.07.001into different mesodermal cell lineages, and which can be
isolated from adult tissues (e.g. bone marrow (BM), the most
studied source) or postnatal tissues (e.g. umbilical cord
matrix). An increasing body of evidence has demonstrated
the immense clinical potential of SCs, mainly resulting from
their immunomodulatory properties and multilineage differ-
entiation ability. Some examples of the latter include the
226 P.H. Oliveira et al.treatment of myocardial infarction (Strauer et al., 2002; Chen
et al., 2004), osteogenesis imperfecta (Horwitz et al., 2001),
and in the context of hematopoietic cell transplantation,
improving hematopoietic engraftment and preventing orattenuating the effects of graft-versus-host-disease (Lazarus
et al., 2005).
Since BMSC titers are typically very low and decline with
age (roughly 0.01% of BM mononuclear cells in a newborn in
227Impact of hypoxia and long-term cultivation on genomic stability and mitochondrial performanceopposition to 0.00005% in elderly patients) (Caplan, 2007), it
becomes necessary to expand these cells ex vivo in order to
achieve clinically relevant cell numbers. Concurrently, other
sources such as the adipose tissue are emerging as an
alternative source of SCs, which can thus be obtained in a
less invasive way, and in larger titers than those found in the
BM (Gimble and Guilak, 2003).
The process of expanding adult stem cells in vitro, namely
SCs, has proven to be challenging not only from the bioengi-
neering standpoint (Dos Santos et al., 2010; Eibes et al., 2010;
Santos et al., 2011), but also from the perspective of
maintaining stem cell characteristics while avoiding or delaying
senescence and genetic instability (Tarte et al., 2010; Sensebe
et al., 2011; Ueyama et al., 2012). In this sense, several studies
have pointed out that the ex vivo propagation of adult stem
cells, particularly for extended periods of time, induces a
cascade of cellular events that lead to a decay in proliferation
rate and differentiation potential (Bonab et al., 2006),
compromised mitochondrial function (Rubio et al., 2008), and
increased number of chromosomal abnormalities (Izadpanah et
al., 2008; Tarte et al., 2010). Moreover, the use of low oxygen
tensions (1–5%, referred to as hypoxia) has been exploited as a
strategy to mimic the physiologic microenvironment of these
cells in order to increase cell proliferation (Dos Santos et al.,
2010; Tsai et al., 2011). Nevertheless, themechanisms involved
are poorly understood and some conflicting results have been
obtained. One example of the latter includes determining to
what extent hypoxic environments affect the expression of
certain cell-cycle-related or DNA repair genes, therefore
disturbing genetic stability (Bindra et al., 2007; Rodriguez-
Jimenez et al., 2008; Yeung et al., 2008). The role of hypoxia as
modulator of several functional mitochondrial properties in
adult stem cells, namely its metabolic activity or the presence
of deleterious mutations, also remains to be clarified (Rehman,
2010).
In this work, we present a side-by-side comparison of
human BMSCs and ASCs concerning the impact of prolonged
passaging (NP10, PP) and use of a low oxygen tension (2%) on
the expression of the proto-oncogene c-MYC and tumor
suppressor gene p53, as well as on critical genes that mediate
mismatch repair (MMR), homologous recombination (HR) and
non-homologous end-joining (NHEJ). We further examined the
influence of the aforementioned conditions in the onset of
microsatellite instability (MSI), changes in telomere length,
and mitochondrial performance. In addition, to gain insight
into so far unnoticed discrepancies between BMSCs and ASCs
responses to hypoxia, our results provide data potentiallyFigure 1 Morphology, analysis of surface markers and differentiat
fibroblastic morphology in early passages (EP, P1–P5) in both normo
irregular shape typical of a pre-senescent/senescent state after pro
morphology were observed in ASCs (Supplementary Fig. 1A). The I
maximum Feret's diameter (B). The morphology of BMSCs and ASCs ex
bars) at early passages was compared with prolonged passage cel
population doublings (PDs) did not change significantly between BMS
alternatively under normoxia for ten consecutive passages (B). (C) R
and PP. Similar results were observed with ASCs (Supplementary Fig.
BMSCs along adipogenic (left) and osteogenic (right) lineages. Aft
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were observed with ASCs (Supplementary Fig. 1B).useful in the specification of quality-control requirements for
stem-cell-based products for use in Cellular Therapy applica-
tions. Moreover, they extend the current knowledge on the
continuous and far reaching changes occurring at the cellular
level, that need to be taken into accountwhen considering the
ex vivo expansion of SCs for therapeutic applications.
Materials and methods
Human bone marrow and adipose-derived stem/
stromal cell cultures
Human bone marrow aspirates were obtained from healthy
donors (n=3, ages between 42 and 47 years old, P1–P5)
after informed consent, at Instituto Português de Oncologia
Francisco Gentil, Lisboa, Portugal. BMSCs were isolated and
characterized according to the protocol described by Dos
Santos et al. (2010). ASCs were obtained from adult human
subcutaneous adipose tissue (n=4, ages between 25 and
59 years old, P1–P5), as described previously (Gimble and
Guilak, 2003). Both cell types were cultured in Dulbecco's
Modified Essential Medium, DMEM (Gibco, Grand Island, NY)
supplemented with 10% qualified fetal bovine serum, FBS
(Gibco) and 1% penicillin–streptomycin–fungizone (Gibco)
at 37 °C and 5% CO2 in a humidified atmosphere. Hypoxia
cultivation of BMSCs and ASCs was established in a Napco
8000WJ incubator (Thermo Scientific, Waltham, MA) flushed
with premixed 2% O2 and 5% CO2 at 37 °C. Exhausted
medium was changed twice a week and cell passaging was
performed near confluence (N80%) under normoxia. Briefly,
cells were washed with phosphate buffered saline (PBS)
(Gibco) and detached from the T-flask by adding Accutase
solution (Sigma, St. Louis, MO) for 7 min at 37 °C. Cell
number and viability were determined using the Trypan Blue
(Gibco) exclusion method. Replating was performed at an
initial density of 5000 cells/cm2. The number of population
doublings (PDs) was calculated according to PDs=log[(number
of harvested cells)/(number of plated cells)]/log(2).
Cell morphological analysis
Analysis of cell morphology was routinely performed using
bright field microscopy (Olympus, Hamburg, Germany). Image
analysis in terms of cell surface area (spreading) and Feret's
diameterwas conducted using the NIH ImageJ software v. 1.44
(http://rsbweb.nih.gov/ij/) after outlining cell boundaries.ion potential of SCs. Representative images of BMSCs exhibiting a
xia and hypoxia (A, EP Nx, EP Hx), or showing an enlarged and
longed passaging (NP10) in normoxia (A, PP). Similar changes in
mageJ software was used to compute cell spreading area and
panded under normoxia (Nx, gray bars) or 2% hypoxia (Hx, black
ls under normoxia (white bars). *pb0.05. Also, the number of
Cs and ADSc expanded under normoxia or hypoxia for 14 days, or
epresentative analysis of BMSC surface markers for EP Nx, EP Hx
1C). (D) Representative images of the in vitro differentiation of
er adipogenic differentiation, Oil Red O staining revealed the
entiation, alkaline phosphatase was used to stain osteogenic
sence of calcium deposits (shown in black) (right). Similar results
Figure 2 Changes in the expression level of DNA repair genes, tumor suppressor p53, and c-MYC proto-oncogene in BMSCs and ASCs
expanded for different incubation times under normoxia (Nx), 2% hypoxia (Hx) and 48 h after reoxygenation (AR). (A, B) Fold change
in the expression of HR (RAD51, BRCA1), NHEJ (Ku80), and MMR (MLH1) genes, normalized to T0. (C, D) Fold change in the expression
of p53 and c-MYC, normalized to T0. GAPDH was used as housekeeping gene (results using ACTB are shown in Supplementary Fig. 2A).
Results are shown for both cell sources expanded for 21 days under Nx and Hx or for PP in Nx. *pb0.05, **pb0.01, ***pb0.001.
228 P.H. Oliveira et al.The latter parameter is the maximum measured distance
between parallel lines tangent to the cell boundaries and
perpendicular to the ocular scale. At least three fields of view
per condition and per donor were used (n=20), and each
measurement was performed in triplicate.Immunophenotyping and in vitro multilineage
differentiation
Immunophenotyping was performed according to (Santos et al.,
2011). Briefly, a panel of PE-conjugated mouse anti-human
monoclonal antibodies was used: CD73 (Becton Dickinson
Immunocytometry Systems, San Jose, CA), CD80 (BioLegend,
San Diego, CA), CD90 (R&D Systems, Minneapolis, MN), CD105
(Invitrogen, Carlsbad, CA), and human leukocyte antigen
(HLA)-DR (Becton Dickinson Immunocytometry Systems). Ap-
propriate isotype controls were used in every experiment and a
minimum of 10,000 events was collected for each sample. Cells
were analyzed in a FACSCalibur (Becton Dickinson Biosciences)
using the CellQuest software (Becton Dickinson Biosciences).For in vitro multilineage differentiation, SC cultures were
allowed to reach confluence, andwere subsequently induced to
differentiate towards the adipogenic and osteogenic lineages by
replacing the expansion medium with those provided in the
STEMPRO® Adipogenesis and Osteogenic Differentiation medi-
um (Gibco) respectively. Cultureswere re-fed every 3 days for a
period of two weeks, after which their differentiation potential
was evaluated. For this purpose, cells were washed with PBS,
fixedwith 2% (w/v) paraformaldehyde (PFA) (Sigma) for 30 min,
and washed again with deionized water (dH2O). The extent of
adipogenic differentiation was assessed by Oil Red O staining
(Sigma) (0.3% in isopropanol) for 1 h at room temperature, after
which cells were washed with dH2O and visualized under the
microscope. Osteogenic differentiation was evaluated by
staining for alkaline phosphatase using Naphtol AS-MX phos-
phate and Fast Violet (both from Sigma) for 45 min at room
temperature, washing three times with dH2O, and visualizing
under the microscope. For von Kossa staining, cells were
incubated with silver nitrate (2.5% w/v) (Sigma) for 30 min,
washed three times with dH2O, and visualized under the
microscope.
Figure 3 Impact of hypoxia and PP on the onset of microsatellite instability (MSI) and on relative mean telomere length (RMTL). (A)
The occurrence of MSI was evaluated in the Bethesda panel of markers (BAT25, BAT26, D5S346, D17S250, and D2S123) as well as in
TP53Alu and RB. Minus (−) or plus (+) signs respectively denote MSI negative and MSI positive samples. The result was scored as
positive when at least one donor revealed MSI. Overall, samples were found to be stable (MSI-S) if no unstable locus was found or
low-frequency (MSI-L) for those in which less than 40% of the loci were unstable. Representative electropherograms depicting
unstable loci are also shown (t0 — blue; Hx 21 days — red; PP — green), with additional or missing peaks indicated by arrows. (B)
Fold-change in RMTL using GAPDH as comparison (results using ACTB are shown in Supplementary Fig. 2B). *pb0.05, **pb0.01,
***pb0.001.
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chain reaction (RT-PCR)
Total RNA from BMSCs and ASCs was extracted using the High
Pure RNA isolation kit (Roche Diagnostics, Mannheim, Germany)
following the manufacturer's instructions. Total RNA samples
(1 μg) were independently reverse-transcribed by oligo(dT)
priming using the Transcriptor First-Strand cDNA synthesis kit
(Roche). All RT-PCR reactions were carried out in a Roche Light
Cycler™ detection system and in a 20 μl final volume containing
2.0 mM MgCl2 solution, 0.2 μM of each primer, 2.0 μl of sample
and SYBR Green I mixture. The amplification program was as
follows: 10 min at 95 °C followed by 40 cycles of 10 s at 95 °C,
5 s at 55 °C and 10 s at 72 °C. Reactions were finally kept at
70 °C for 30 s and heat-denatured over a temperature gradient
of 0.1 °C/s from 70 to 95 °C. The comparative threshold
cycle (CT) method was used to calculate the expression of
MLH1, RAD51, BRCA1, Ku80, p53 and c-MYC relative to twoendogenous reference genes (GAPDH and ACTB) (primer
sequences are listed in Supplementary Table 1). While some
studies have provided evidence for hypoxic-mediated changes
in GAPDH gene expression, others do not show such relation
(Said et al., 2007; Rodriguez-Jimenez et al., 2008; Basciano et
al., 2011). We verified that under our experimental conditions
the expression of both genes did not significantly change
(pN0.05) with varying oxygen tension nor prolonged passaging.
The ΔCT parameter was calculated for both normoxic and
hypoxic samples as ΔCT=CT (gene of interest) −CT (house-
keeping gene). The fold variation in gene expression was finally
given by 2−ΔΔCT where ΔΔCT=ΔCT (time t) −ΔCT (time 0).Microsatellite instability (MSI) analysis
Genomic DNA was extracted from BMSCs and ASCs by using the
Wizard Genomic DNA purification kit (Promega, Madison, WI),
230 P.H. Oliveira et al.and quantified spectrophotometrically. For the determination
of microsatellite instability (MSI), we evaluated TP53Alu, RB,
and the Bethesda panel of five microsatellite markers
recommended by the National Cancer Institute: two mononu-
cleotide repeats (BAT25, BAT26) and three dinucleotide
repeats (D5S346, D2S123, and D17S250). All forward primers
were fluorescein-labeled with [6-FAM] (Supplementary Table
1). PCR reactions were carried out in a 20 μl mixture
containing 100 ng gDNA, 0.5 μM of each primer, 2.5 mM
MgCl2, 500 μM each DNTP and 0.5 U of AmpliTaq Gold DNA
polymerase (Applied Biosystems, Foster City, CA). PCR was
carried out in a Biometra T Gradient thermal cycler
(Goettingen, Germany) according to the following program:
10 min at 94 °C followed by 40 cycles of 45 s at 94 °C, 45 s at
Ta °C, 45 s at 72 °C, and a final extension step of 10 min at
72 °C. The values for Ta were based on (Dietmaier et al.,
1997), and were 52 °C (D17S250), 55 °C (D5S346), 58 °C
(BAT25, BAT26, TP53Alu, and RB), or 60 °C (D2S123). Finally,Figure 4 Evaluation of mitochondrial properties in SCs. (A) Seque
three ASC donors allowed us to determine the corresponding hapl
essentially common variants located in the D-loop region of mtDNA a
or expansion under hypoxia. One exception was the m.521ANG v
representing, to the best of our knowledge, a novel homoplasmic p
content (B), intracellular ATP (iATP) (C), and membrane potential (
more than twofold in the mtDNA content and iATP of BMSCs. *pb0.0PCR products were 10–20-fold diluted in water, and 1.5 μl of
the latter was mixed with 18 μl of deionized formamide
(Applied Biosystems) and 0.5 μl GeneScan ROX 350 size
standard (Applied Biosystems). MSI status was categorized
according to the following criteria: stable (MSI-S) if none of
the loci revealed MSI, low-frequency (MSI-L) if less than 40% of
the loci were unstable, high-frequency (MSI-H) if more than
40% of the loci were unstable (Dietmaier et al., 1997). To
exclude potential artifacts inherent to the PCR process, MSI
status was only scoredwhen changes could be reproduced in at
least two independent PCR reactions.Telomere length analysis
Relative mean telomere length (RMTL) was assessed by real
time PCR using a modified version of the assay initially
described elsewhere (Cawthon, 2002). Briefly, the telomerencing of the complete mitochondrial genomes of three BM and
ogroup, as well as non-haplogroup variations. The latter were
nd their number or status was not observed to change during PP
ariation, which was not found in specialized databases, thus
olymorphism. Prolonged passaging led to an increase of mtDNA
Δψm) (D), whereas expansion under hypoxia led to a decrease of
5, **pb0.01.
231Impact of hypoxia and long-term cultivation on genomic stability and mitochondrial performancerepeat copy number to single gene copy number (T/S) ratio was
calculated by means of two independent amplification re-
actions: the telomere reaction, which proceeded for 1 cycle at
95 °C for 10 min, followed by 20 cycles at 95 °C for 5 s, 56 °C
for 10 s, and 72 °C for 1 min, and the single gene reaction
(GAPDH or ACTB) which was identical to one described above.
Primer sequences are indicated in Supplementary Table 1. The
T/S ratio for each sample was computed by subtracting the
average GAPDH (or ACTB) CT value from the average telomere
CT.
Mutational analysis of the entire mitochondrial
genome
For the detection of mtDNA mutations we PCR-amplified a set
of 19 overlapping fragments spanning the entire mitochondrial
genome (Supplementary Table 1). PCR was performed in a
50 μl reaction volume containing 300 ng total DNA, 0.5 μM of
each primer, 2.5 mM MgCl2, 500 μM of each DNTP and 2.5 U of
AmpliTaq Gold DNA polymerase. The PCR program consisted of
an initial denaturation step of 7 min at 94 °C followed by 38
cycles of 30 s at 94 °C, 45 s at 55 °C and 1 min at 72 °C, and a
final extension step of 10 min at 72 °C. After gel purification
using a QIAquick gel extraction kit (Qiagen, Valencia, CA), the
PCR products were sequenced and subsequently compared
with the revised Cambridge Reference Sequence (rCRS,
accession number NC_012920) using BLAST2Seq (www.ncbi.
nlm.nih.gov/blast/bl2seq/wblast2.cgi) in order to detect poly-
morphisms andmutations. The former analysis was repeated in
two independent PCR and sequencing reactions for both
forward and reverse strands. Haplogroup-associated variants
of each mtDNA contig were subsequently identified by using
PhyloTree (van Oven and Kayser, 2009) (http://www.
phylotree.org), and its most recent web-based application
Haplogrep (http://haplogrep.uibk.ac.at/) (Kloss-Brandstatter
et al., 2011).
Analysis of relative amount of mtDNA content
Total cellular DNA was isolated using the QIAamp DNA Mini
Kit (Qiagen) and concentrations were spectrophotometri-
cally determined. The content of mtDNA relative to
nuclear DNA was determined by co-amplifying a 151-bp
mt ND5 fragment and a nuclear fragment from the GAPDH
or ACTB genes using real time PCR. The program used was
identical to that described above for gene expression
analysis. Primers used are indicated in Supplementary
Table 1. The ratio of mtDNA to genomic DNA was calculated
with ΔCT=CT (ND5)−CT (GAPDH or ACTB). Fold difference
in mtDNA content was given by 2−ΔΔCT, where ΔΔCT=ΔCT
(test group)−ΔCT (control).
Measurement of ATP content
Intracellular ATP (iATP) content was determined by using the
ATP determination kit (Invitrogen) according to manufacturer's
instructions. This kit allows the determination of very low
concentrations of ATP through the light-emitting oxidation of
D-luciferin by luciferase. Briefly, cells were re-suspended in
distilled water at a concentration of 106 ml−1, boiled for 2 min
and centrifuged (5 min, 12,000 g) to eliminate DNA and othercell debris. Samples were taken from the supernatant and
bioluminescence was monitored at 560 nm on a multi-well
bioluminescence/fluorescence plate reader (Cary Eclipse,
Varian). Twenty reads were performed per well/sample and
each sample was analyzed at least in triplicate.Flow cytometric analysis of mitochondrial mem-
brane potential (Δψm)
Mitochondrial membrane potential (Δψm) was evaluated by
using the MitoProbe JC-1 assay kit (Molecular Probes, Eugene,
OR) according to the manufacturer's instructions. Briefly, cells
were detached from culture flasks, washed, and resuspended
in PBS at approximately 106cells/ml. Cells were then incubated
with the Δψm‐dependent cationic dye JC-1 (5,5′ 6,6′‐
tetrachloro-1,1′ 3,3′ tetraethylbenzimidazolcarbocyanine io-
dide) (2 μM final concentration) at 37 °C for 15–30 min in the
dark. Uncoupling with the protonophore carbonyl cyanide
3-chlorophenylhydrazone (CCCP, final concentration 50 μM) for
30 min at 37 °C was also used as positive control. Mitochondria
with elevated Δψm concentrate JC-1 into aggregates showing
red fluorescence whereas mitochondria with low Δψm cannot
concentrate JC-1 and show green fluorescence. Sample
analysis was performed using the FACSCalibur equipment.
JC-1 monomers were detected in FL1 (530/30 nm bandpass
filter) while JC-1 aggregates were detected in FL2 (585/42 nm
bandpass filter). At least 10,000 events were analyzed in each
run and the FL2/FL1 ratio was calculated in order to reflect
changes in Δψm.Statistical analysis
Data are presented asmean±standard error of themean (SEM)
of at least three independent experiments. Comparisons were
performed using a two-tail unpaired t-test or a one sample
t-test (real time PCR).
Results
Morphology of SCs, immunophenotyping and in vitro
differentiation
Morphological changes took place during the course of
long-term ex vivo expansion of SCs. At lower passages (P1–
P5), BMSCs presented a typical homogeneous fibroblast-like
shape (Fig. 1A), whereas at later stages (NP10), cells acquired
an enlarged, irregular and flattened shape,with inclusions and
debris visible in the medium and supernatant (Fig. 1A). No
differences were noticed in themorphology of BMSCs and ASCs
expanded under hypoxia and normoxia (Fig. 1A, Supplemen-
tary Fig. 1A). To better evaluate the cell structural changes,
we performed a morphometric analysis using the ImageJ
software, in order to compute the spreading area and
maximum Feret's diameter (longest distance between any
two points along the cell boundary). Both parameters were
found to be roughly similar between the two cell sources, and
although considerably increased under PP in normoxia, they
did not appear to be significantly affected in cells expanded
under hypoxia (b21 days of exposure) (Fig. 1B). The average
232 P.H. Oliveira et al.values for cell spreading area and Feret's diameter at earlier
passages were respectively 444 μm2 and 58.5 μm. Amean fold
increase of 6.5 and 2.6 was observed in the latter parameters
between early and late passage cells, respectively (Fig. 1B).
The number of population doublings did not change signifi-
cantly between BMSCs and ASCs when these were cultured
under normoxia or hypoxia for a period of 14 days, or when
expanded for ten passages under normoxia (Fig. 1B).
For immunophenotypic analyses we evaluated a panel of five
surface markers (Dominici et al., 2006). As expected, all SCs
were positive for CD73, CD90 and CD105, and negative for CD80
and (HLA)-DR (the largemajority above 99%) (Fig. 1C, BMSCs are
shown as example). Similarly to what has been described by
others (Bernardo et al., 2007; Dos Santos et al., 2010), no
significant differences for expression of these surface markers
were verified between BMSCs and ASCs expanded for a low
number of passages under hypoxia and normoxia, or prolonged
passaging (PP) (compare Fig. 1C with Supplementary Fig. 1C).
We have also confirmed the potential of these cells to
differentiate along the adipogenic and osteogenic lineages.
Oil Red O was used to stain intracellular lipid vesicles
(Fig. 1D, left, BMSCs are shown as example), while alkaline
phosphatase and von Kossa staining were used to identify
osteogenic progenitors and calcium deposits (Fig. 1D, right,
BMSCs are shown as example). Similar results were obtained
for ASCs (Supplementary Fig. 1B).Effect of hypoxia and prolonged passaging on the
expression of DNA repair genes, p53 and c-MYC
Since some studies have implicated hypoxia as a promoter
of “stemness” and cell proliferation, we decided to
investigate its effect as well as that of prolonged passaging
(PP), on the expression of genes involved in HR (RAD51,
BRCA1), NHEJ (Ku80), and MMR (MLH1) pathways. Low
passage (P1–P3) human BMSCs and ASCs were exposed to
normoxic (20% O2) or hypoxic (2% O2) conditions for a period
of time ranging from 6 h to 21 days. After this 3-week
period, normoxic cells were allowed to expand for a total of
10–20 passages (PP), while hypoxic cells were submitted to
a reoxygenation period of 48 h (AR, after reoxygenation).
We considered this period of reoxygenation to be long
enough to allow the stabilization of gene expression profiles
(if that being the case), but yet short enough to still allow
evaluation of plating effects (see below).
In the first 21 days under normoxia, the expression levels of
the four genes did not differ significantly from that of the
control for both cell sources. (Figs. 2A and B, left). However, a
surprising and rather pronounced (3- to 5-fold) increase in
gene expression was observed mainly within the first 24 h
upon plating for the two HR genes and for both cell sources,
regardless of the O2 tension studied (Figs. 2A and B (right),
with exception for BRCA1 in hypoxic BMSCs). Since BRCA1 was
recently implicated in the adhesion, spreading, andmotility of
breast cancer cells by interaction with F-actin and the ezrin/
radixin/moesin complex (Coene et al., 2011), it thus seems
plausible that this gene together with RAD51, may also play an
important role in the adhesion of SCs to culture-treated
plastic. Prolonged passaging in normoxia led to a significant
down-regulation of Ku80 and BRCA1 in BMSCs, and RAD51 and
BRCA1 in ASCs.Under hypoxia, we observed a down-regulation of MLH1
and BRCA1 as soon as 6 h, but amore generalized repression of
the four genes was only visible after 21 days. Moreover,
changes in the expression of DNA repair genes, seemed to
generally occur more slowly for ASCs than for BMSCs (compare
Figs. 2A and B, right). After a 48-h period of reoxygenation,
cells previously exposed to hypoxia had expression levels close
to those of time 0, with the exception of RAD51 whose
over-expression was still around 4–5‐fold (Figs. 2A and B,
right). The latter is probably an effect reminiscent of cell
passaging, which points to a delayed recovery of RAD51 basal
levels of expression.
We also evaluated the impact of hypoxia and PP on the
expression of the tumor suppressor gene p53 and the c-MYC
proto-oncogene. Despite their well-known involvement in a
plethora of biological processes that include cell‐cycle
progression, DNA replication, apoptosis, and angiogenesis,
studies focusing on the expression levels of p53 and c-MYC
during in vitro expansion of stem cells are rather limited and
have generated conflicting results. In our work we found
that for both types of cells the responses of p53 and c-MYC to
hypoxia and prolonged passaging are similar. Upon long-term
cultivation involving consecutive passages (NP10), for both
BMSCs and ASCs, these genes were down-regulated (Figs. 2C
and D), as previously reported by other authors (Kim et al.,
2009; Efimenko et al., 2011).
Regarding the effect of hypoxia, it was previously demon-
strated that it down-regulates p53 protein levels when
uncoupled from acidosis, whereas the opposite effect is seen
in the presence of hypoxia-induced medium acidification
(Schmaltz et al., 1998; Pan et al., 2004). In our case, the
buffering capacity of the medium will in principle only allow
small pH variations, which is in line with the observed p53
repression (Figs. 2C and D). Regarding the proliferation-
promoting transcription factor c-MYC, we have observed no
effect at the transcriptional level under hypoxic conditions
(Fig. 2D), in agreement with other results in the literature
(reviewed by Huang, 2008). Nonetheless, severe or prolonged
hypoxia is known to result in c-MYC degradation and its
displacement from the promoter regions of MMR genes (Bindra
and Glazer, 2007a). Similar gene expression data were obtained
when using the beta-actin (ACTB) housekeeping gene instead of
GAPDH (see Supplementary Fig. 2).Hypoxia promotes microsatellite instability and
maintains telomere length
Since down-regulation of DNA repair genes is known to
induce genomic instability (Vaish, 2007; Rodriguez-Jimenez
et al., 2008), we further examined the status of several
microsatellite sequences present in the genomic DNA of both
cell sources. The markers chosen for this analysis were
TP53Alu, RB, and those belonging to the Bethesda panel
(BAT25, BAT26, D5S346, D17S250, and D2S123). From day 14
onwards, we observed fragments absent in the dinucleotide
markers D17S250 and D2S123 of both BMSCs and ASCs
cultured under hypoxia, whereas the same instabilities and
changes in D5S346 were only seen after PP for “normoxic”
cells (Fig. 3A). Since MSI was found to be present in only one
or two markers, it should be respectively classified as stable
(MSI-S) or low frequency (MSI-L).
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were able to maintain telomere length, while the latter
decreased over time under normoxia, consistent with prior
reports (Izadpanah et al., 2008) (Fig. 3B and Supplementary Fig.
2B). Also, no statistically significant differences were seen
between BMSCs and ASCs (Fig. 3B). Previous evidence has shown
that human SCs are typically telomerase-low/negative
(Zimmermann et al., 2003), although contrasting results have
been reported (Pittenger et al., 1999). More recently, Tsai et al.
(2011) have shown that human BMSCs expanded by up to 100
population doublings under hypoxic conditions (1% O2), had
greater telomerase activity and telomere length than cells
expanded under normoxia (i.e. 20%). Instead of an ectopic
expression of the human telomerase gene, the authors exploit
the natural ability of SCs to survive under hypoxic conditions in
order to increase their lifespan. Our results are in line with
these data, and extend such conclusions to human ASCs at least
for a two-week period.Effect of hypoxia and prolonged passaging on
mitochondrial performance
The evaluation of mitochondrial function as a quality control
procedure during ex vivo expansion of stem cells, has gained
increasing interest in the recent years. Nevertheless, some
aspects remain poorly explored, such as a thorough search
for genetic aberrations in mtDNA. The results obtained in
this work support the concept of a relatively stable
mitochondrial genome, both in terms of small indels as
well as larger aberrations. The majority of mutations found
were haplogroup-specific or occurred at highly polymorphic
repeat tracts, and their load did not change under hypoxia or
after PP (Fig. 4A). One such example is the mononucleotide
C tract (C6–10TC6) commonly termed D310, which is located
within the displacement loop (D-loop) region. Mutations
found within the D310 region were observed in all samples
with exception of those from donor 2, and consisted in 1 or
2-bp C insertions (thus lying within the polymorphic length
range of 6 C–10 C (Legras et al., 2008)) (Fig. 4A). Themutation
m.523_524delAC found in BMSCs from donor 2 is relatively
frequent and arises from slippage events occurring within a
short microsatellite of 5 tandem AC repeats. Both the
m.15626CNT synonymous transition located in the cyto-
chrome b gene and m.16271TNC located in the D-loop have
been previously identified (Ingman and Gyllensten, 2006;
www.mitomap.org, 2011). Yet, a thorough search in the
literature as well as in specialized databases (Ingman and
Gyllensten, 2006; www.mitomap.org, 2011) led us to conclude
that m.521ANG is most probably, a novel homoplasmic
polymorphism. Another variant found in some of our samples
was 16519TNC (Fig. 4A), which has been shown to be related to
an increased risk of development of several types of
carcinomas, or to be in linkage disequilibrium with functional
variants that increase that risk (Bai et al., 2007; Peng et al.,
2011).
Since some of the latter mutations map within the
non-coding D-loop region involved in the regulation of replica-
tion and transcription, we hypothesized that changes in copy
number could occur. In our studies with SCs, we did not find
evidence of functional impairment ofmitochondrial activity as a
result of the presence of these mutations. In particular, we didnot find significant differences in the mitochondrial content of
the several donors (data not shown), suggesting that none of
thesemutations is per se the causative agent of any detrimental
effect.
We further evaluated the effect of hypoxia and PP on other
performance parameters such as the number of mitochondrial
genomes, iATP, and membrane potential (Δψm). We observed
that all of the latter parameters roughly increased 1.8-fold
after prolonged passaging for both cell sources (Figs. 4B–D).
These changes are characteristic of a more mature state
associated with differentiation or senescence (Prigione et al.,
2010; Rehman, 2010).
After 21 days in hypoxia, the number of mtDNA genomes
decreased more than half in BMSCs, whereas no significant
difference was seen in ASCs (Fig. 4B and Supplementary
Fig. 2C). These results were found to correlate with
variations in iATP levels for both types of cells (Fig. 4C).
Taking into consideration the role of p53 inmaintainingmtDNA
oxidative phosphorylation and copy number (Lebedeva et al.,
2009), its hypoxia-mediated down-regulation likely contribut-
ed to the observed decrease in iATP content and number of
mitochondrial genomes. Moreover, the decrease in mtDNA
content and the previously observed down-regulation of
RAD51 under hypoxia are two events that apparently cannot
be dissociated. The mtDNA was recently shown to be a
substrate for RAD51, in a pathway that possibly facilitates the
completion of mtDNA replication in the presence of DNA
lesions (Sage et al., 2010). Older passage cells also have an
increased amount of ROS (as shown by changes in Δψm)
(Fig. 4D) and are more exposed to oxidative damage, a fact
that may jeopardize their potential clinical use.Discussion
In this work we have in vitro expanded BMSCs and ASCs under
distinct oxygen tensions and PP, to specifically evaluate and
compare their DNA repair machineries as well as effects on
genomic stability and mitochondrial performance. First, our
gene expression analysis suggests a gradual decline of DNA
repair capacity over time, which may lead to a concerted
decrease in stem cell function, emergence of genomic
instability, and activation of apoptosis signaling pathways.
Previous work has shown that the two HR genes BRCA1 and
RAD51 are co-repressed under hypoxia through binding of
E2F4/p130 complexes to their upstream promoters (Bindra et
al., 2005; Bindra and Glazer, 2007b). In the case of the MMR
gene MLH1, its transcriptional down-regulation under hypoxia
has been shown to be associated with deacetylation and
trimethylation of histone H3 on lysine 9, thus impairing
binding of the SP1 transcriptional factor at the corresponding
promoter region (Rodriguez-Jimenez et al., 2008). Regarding
the expression of the NHEJ gene Ku80, conflicting results
obtained using several cancer cell lines are reported in the
literature. Meng et al. (2005) showed repression of several
NHEJ gene family members following chronic hypoxia (72 h at
0.2% O2). In another study, no change in Ku80 expression was
detected after 48 h at 0.01% O2 (Bindra et al., 2005).
Concerning the tumor supressor p53 and the proto-oncogene
c-MYC, they were found to be down-regulated after PP. The
fact that p53 mRNA levels may decrease or remain unaltered
after PP is not necessarily at odds with its role in activating
234 P.H. Oliveira et al.senescence, since in some cases, up-regulation is only
observed at the protein level (Izadpanah et al., 2008). Another
study presents contradicting data, in the sense that it refers to
the absence of significant changes in p53 at both mRNA and
protein levels after prolonged in vitro propagation of human
SCs (Noh et al., 2010). These discrepancies may in part be due
to different experimental conditions (e.g. culturemedium), or
to the use of heterogeneous cell populations that are more or
less prone to enter a senescent stage. An example found in
BMSCs is the link between donor age and increasing p53
activity (Zhou et al., 2008), which supports the view that in
vivo aging directly affects the proliferative and differentiative
potential of cells in vitro. In the case of c-MYC, its expression
levels have been reported to decrease during the stage of
pre-senescence, increasing again as cells move towards a
senescent, post-senescent or eventually to a transformed
state (Rubio et al., 2008). Since all BMSCs and ASCs analyzed in
this study showed evidence of entering a pre-senescence/
senescence phase between P10 and P20 (in agreement with
data from other studies (Bernardo et al., 2007)), the c-MYC
down-regulation observed in these cells comes as no surprise.
We also show that down-regulation of DNA repair genes
under hypoxia favoured the onset of MSI, particularly within
D5S346, D17S250 and D2S123. These findings are consistent
with those of several groups who have reported preferential
instability in these loci in a wide range of MSI-L cancer cell
lines (Murphy et al., 2006; Deschoolmeester et al., 2008). This
bias has led to the supposition that MSI-L andMSI-H are distinct
entities, which seem to arise from distinct biological processes
(Murphy et al., 2006). Our MSI analysis supports this theory and
further extends it to human SCs, suggesting that the onset of
the MSI-L phenomenon might follow a common pathway.
Others have found that lowering the O2 percentage to 1%
apparently results in an earlier onset and increase of MSI in
neural stem cells and SCs, both using the Bethesda panel, as
well as in othermarkers (Rodriguez-Jimenez et al., 2008). This
fact is suggestive of an even more pronounced repression of
the MMR system, and an indicator that excessively low O2
tensions should be avoided, as they might be detrimental for
genetic stability.
Currently, there is limited information on the stability of the
mitochondrial genome during expansion of adult cells. A very
limited number of studies have reported the detection of
mutations in the mtDNA of human colonic crypt stem cells as
well as in adult and embryonic primate stem cells (Taylor et al.,
2003; Gibson et al., 2006). More recently, it has been suggested
that stem cells may have an inherent mechanism to efficiently
repair most mtDNA lesions, or they are simply not subjected to
enough oxidative damage in their niche (Alison et al., 2010). In
this context, one important aspect to consider is whether this
scenario could be changed during ex vivo expansion. In this
work, we recurrently found mutations occurring within the
D-loop region D310. The latter has been regarded as a
mutational hotspot in primary tumors, and has been described
as extremely sensitive to oxidative damage and electrophilic
attack (Sanchez-Cespedes et al., 2001; Peng et al., 2011). Yet,
the findings that D310 mutations are also present in
non-cancerous cells (albeit at a lower frequency), and that
alterations are typically confined to the polymorphic length
range, ultimately suggest that abnormalities in this region may
be concurrent, but not causative agents of a cancerous state
(Legras et al., 2008; Chatterjee et al., 2011). Curiously, anassociation can be established between variations in the D310
region, and the presence of a family of hot-spot motifs based
around the degenerate 13-mer CCNCCNTNNCCNC. The latter
has been implicated in recruiting meiotic crossover events in
the human genome, as well as in promoting the mitochondrial
common deletion (Myers et al., 2008). On the basis of our
observation, that the D310 region matches the degenerate
consensus, we hypothesize that the presence of the full 13-mer
motif (or internal sub-motifs) might facilitate the occurrence of
slippage events at this locus, thus enhancing the mutation rate.
Two aspects of this work merit some discussion. First, we
were unable to analyze BMSCs from young donors. Never-
theless, it has been shown previously that similar down-
regulation of DNA repair genes and onset of MSI under
hypoxia occurs in samples from donors as young as 19 years
old (Rodriguez-Jimenez et al., 2008). Secondly, one
important caveat with our procedure is that hypoxic cells
were passaged under normoxic conditions. This limitation is
also shared with the majority of published studies that deal
with low oxygen tensions. In this sense, we must recognize
the need to further clarify the real impact of transiently
handling hypoxia expanded cells under non-hypoxic condi-
tions, and if this has somehow biased the conclusions of the
many existing publications. Although dedicated equipment
is commercially available for this purpose, its high cost has
greatly limited a wider application.
One interesting detail unveiled by our data concerns the
response of ASCs to hypoxic environments. Although studies
focusing on the role of hypoxia on human ASCs are not
abundant, these point out that low oxygen tensions do not
seem to maintain stem cell characteristics or enhance
proliferation in a similar fashion to what has been described
for human BMSCs (Ma et al., 2009). Our results, both in terms
of gene expression and mitochondrial response to hypoxia,
collectively point to a similar conclusion: ASCs react to
hypoxic environment more slowly than BMSCs. The reasons
behind this behaviour are still unclear, but it is possible that
the different characteristics of each cell niche (e.g. degree of
vascularization, oxygen tension, cell-cell interactions), deter-
mine distinct sensitivities to hypoxia ex vivo. In this sense, it
becomes important, from the bioengineering point of view,
to clarify in more detail if the use of hypoxia during SC
expansion (particularly ASC), brings any clear benefit in the
typical time frames used to achieve clinically relevant cell
numbers.Conclusions
The results of this study are significant for a deeper under-
standing of the cellular changes that take place during ex vivo
expansion of BMSCs and ASCs, and appear to concur with
current knowledge on the use of hypoxic environments and the
occurrence of replicative senescence. Relevant standardized
quality controls able to characterize themyriad of changes that
SCs face during culture are currently lacking, and a concerted
effort is needed by both academic and clinical teams to
elaborate valid guidelines. Our study suggests the adoption of
procedures such as the evaluation of the status of the DNA
repair machinery, analysis of a representative panel of MSI
markers, and analysis of mitochondrial performance in quality
control panels of culture expanded SC products. Additional
235Impact of hypoxia and long-term cultivation on genomic stability and mitochondrial performanceinformation will be needed before SCs reach the status of a fully
developed, off-the-shelf therapeutic product.
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